Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today tha This option is part of Emergent’s existing 10-year contract with BARDA for advanced development and ...

H.C. Wainwright & Co. reaffirmed its Buy rating and $15.00 price target for Emergent BioSolutions stock (NYSE:EBS). The ...

In the assessment of 12-month price targets, analysts unveil insights for Emergent BioSolutions, presenting an average target ...

GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S ...

Emergent BioSolutions has a sound turnaround strategy in place that is producing positive results. Emergent BioSolutions' cost-cutting efforts have the company on track for profitability in 2025.

Emergent BioSolutions (NYSE:EBS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Several other equities ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Emergent Biosolutions (EBS – Research Report), with a ...

Emergent BioSolutions (NYSE:EBS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They presently have ...

(RTTNews) - Emergent BioSolutions (EBS), a life sciences company, on Tuesday announced that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and Canada for ...

Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today tha This option is part of Emergent’s existing 10-year contract with BARDA for advanced development and ...

Emergent BioSolutions Inc. (EBS) stock price is 11.19 and Emergent BioSolutions Inc. (EBS) 10-day simple moving average is 10.22. Emergent BioSolutions Inc. (EBS) stock price is 11.19 and Emergent ...